These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 21787388)

  • 1. Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer.
    Pértega-Gomes N; Vizcaíno JR; Miranda-Gonçalves V; Pinheiro C; Silva J; Pereira H; Monteiro P; Henrique RM; Reis RM; Lopes C; Baltazar F
    BMC Cancer; 2011 Jul; 11():312. PubMed ID: 21787388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70).
    Wilson MC; Meredith D; Fox JE; Manoharan C; Davies AJ; Halestrap AP
    J Biol Chem; 2005 Jul; 280(29):27213-21. PubMed ID: 15917240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression.
    Chen H; Wang L; Beretov J; Hao J; Xiao W; Li Y
    Clin Exp Metastasis; 2010 Dec; 27(8):557-69. PubMed ID: 20658178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of lactate/proton symporters MCT1, MCT4, and their chaperone CD147 expressions in urothelial carcinoma of the bladder.
    Choi JW; Kim Y; Lee JH; Kim YS
    Urology; 2014 Jul; 84(1):245.e9-15. PubMed ID: 24857275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44.
    Pinheiro C; Reis RM; Ricardo S; Longatto-Filho A; Schmitt F; Baltazar F
    J Biomed Biotechnol; 2010; 2010():427694. PubMed ID: 20454640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocarboxylate transporters 1 and 4 are associated with CD147 in cervical carcinoma.
    Pinheiro C; Longatto-Filho A; Pereira SM; Etlinger D; Moreira MA; Jubé LF; Queiroz GS; Schmitt F; Baltazar F
    Dis Markers; 2009; 26(3):97-103. PubMed ID: 19597291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD147 expression in advanced cutaneous squamous cell carcinoma.
    Sweeny L; Dean NR; Frederick JW; Magnuson JS; Carroll WR; Desmond RA; Rosenthal EL
    J Cutan Pathol; 2012 Jun; 39(6):603-9. PubMed ID: 22575025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
    Kim Y; Choi JW; Lee JH; Kim YS
    Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer.
    Pinheiro C; Longatto-Filho A; Simões K; Jacob CE; Bresciani CJ; Zilberstein B; Cecconello I; Alves VA; Schmitt F; Baltazar F
    Eur J Cancer; 2009 Sep; 45(13):2418-24. PubMed ID: 19628385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD147 and monocarboxylate transporters MCT1, MCT2 and MCT4 in porcine small intestine and colon.
    Sepponen K; Ruusunen M; Pakkanen JA; Pösö AR
    Vet J; 2007 Jul; 174(1):122-8. PubMed ID: 16901736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report).
    Dell'Anno I; Barone E; Mutti L; Rassl DM; Marciniak SJ; Silvestri R; Landi S; Gemignani F
    J Transl Med; 2020 Sep; 18(1):341. PubMed ID: 32887638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organized metabolic crime in prostate cancer: The coexpression of MCT1 in tumor and MCT4 in stroma is an independent prognosticator for biochemical failure.
    Andersen S; Solstad Ø; Moi L; Donnem T; Eilertsen M; Nordby Y; Ness N; Richardsen E; Busund LT; Bremnes RM
    Urol Oncol; 2015 Aug; 33(8):338.e9-17. PubMed ID: 26066969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression.
    Kirk P; Wilson MC; Heddle C; Brown MH; Barclay AN; Halestrap AP
    EMBO J; 2000 Aug; 19(15):3896-904. PubMed ID: 10921872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors.
    Le Floch R; Chiche J; Marchiq I; Naiken T; Ilc K; Murray CM; Critchlow SE; Roux D; Simon MP; Pouysségur J
    Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16663-8. PubMed ID: 21930917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression.
    Hao J; Chen H; Madigan MC; Cozzi PJ; Beretov J; Xiao W; Delprado WJ; Russell PJ; Li Y
    Br J Cancer; 2010 Sep; 103(7):1008-18. PubMed ID: 20736947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis.
    Bovenzi CD; Hamilton J; Tassone P; Johnson J; Cognetti DM; Luginbuhl A; Keane WM; Zhan T; Tuluc M; Bar-Ad V; Martinez-Outschoorn U; Curry JM
    Biomed Res Int; 2015; 2015():242437. PubMed ID: 26779534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs).
    de Oliveira AT; Pinheiro C; Longatto-Filho A; Brito MJ; Martinho O; Matos D; Carvalho AL; Vazquez VL; Silva TB; Scapulatempo C; Saad SS; Reis RM; Baltazar F
    J Bioenerg Biomembr; 2012 Feb; 44(1):171-8. PubMed ID: 22281667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Monocarboxylate Transporter 1 Is Associated With Better Prognosis and Reduced Nodal Metastasis in Pancreatic Ductal Adenocarcinoma.
    Sukeda A; Nakamura Y; Nishida Y; Kojima M; Gotohda N; Akimoto T; Ochiai A
    Pancreas; 2019 Sep; 48(8):1102-1110. PubMed ID: 31404019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer.
    Pértega-Gomes N; Vizcaíno JR; Gouveia C; Jerónimo C; Henrique RM; Lopes C; Baltazar F
    Prostate; 2013 May; 73(7):763-9. PubMed ID: 23192371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLUT1, MCT1/4 and CD147 overexpression supports the metabolic reprogramming in papillary renal cell carcinoma.
    Almeida LMCA; Silva R; Cavadas B; Lima J; Pereira L; Soares P; Sobrinho-Simões M; Lopes JM; Máximo V
    Histol Histopathol; 2017 Oct; 32(10):1029-1040. PubMed ID: 28028797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.